Making waves.
Changing outcomes.

With our simple approach to addressing a key source of a dysregulated immune response, SeaStar Medical is advancing the science of cell-directed extracorporeal therapy to prevent the devastation of hyperinflammation

chart a new course

Patented technology that transforms key inflammatory messengers from agents of destruction to agents of repair

Improve patient
outcomes

Enables you to alter patients’ disease progression and put them on the path to healing

Keep workflow
on track

Seamlessly integrates into your critical-care workflow

Giving you the power to defeat a serious clinical threat

Critically ill patients in the ICU often face an alarming, urgent situation. A dangerous, dysregulated hyperinflammatory response to infection, trauma or surgery can lead to multiorgan failure and in severe cases, even death.

SeaStar Medical is an innovator with groundbreaking solutions that give you the power to stop this serious threat before it can do irreparable harm to the patients you are fighting for.

Backed by rigorous clinical research and robust scientific evidence, our patented approach is designed to support your clinical end goals including reducing dialysis dependency, improving outcomes, and saving precious lives.

The game-changing selective cytopheretic device (SCD)

With SeaStar Medical’s novel, simple-to-use SCD technology, you can quickly rescue patients from this dysregulated immune response to restore immune balance and help the body return toward homeostasis.

Better outcomes

A shorter treatment regimen to reach the desired effect may reduce dependency on dialysis and time in the ICU. This can help put patients on the road back to recovery sooner and free up resources more quickly.

Making waves. Changing outcomes.